,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,,,,,,,,,,
1,2,S,F,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,cBioPortal,blca_msk_tcga_2020,Bladder Urothelial Carcinoma,"hg19,20:30310017-30310017","hg19,20:g.30310017G>A",0.284,,,,
2,2,S,Y,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,cBioPortal,"chol_icgc_2017, msk_met_2021","Cholangiocarcinoma, Mixed Cancer Types","hg19,20:30310017-30310017","hg19,20:g.30310017G>T",0.141,,,,
3,3,Q,,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,,,,,,,,,,
4,4,S,,,,,,,,,,,C,"IAP-binding motif (IBM), 1-5, ELM",,,,,,,,,,,
5,5,N,,,,,,,,,,,S,"IAP-binding motif (IBM), 1-5, ELM",,,,,,,,,,,
6,6,R,Q,,,,,,,,,,S,,,cBioPortal,cellline_ccle_broad,Mixed Cancer Types,"hg19,20:30310005-30310005","hg19,20:g.30310005C>T",0.344,,,0.0003432522841879,0.0001592863969417
7,7,E,K,,,,,,,,,,S,"Atg8 protein family ligands, 7-10, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30310003-30310003","hg19,20:g.30310003C>T",0.357,,,0.0000000000000000,
8,8,L,,,,,,,,,,,S,"Atg8 protein family ligands, 7-10, ELM",,,,,,,,,,,
9,9,V,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 9-17, ELM|Atg8 protein family ligands, 7-10, ELM",,,,,,,,,,,
10,10,V,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 9-17, ELM|Atg8 protein family ligands, 7-10, ELM",,,,,,,,,,,
11,11,D,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 9-17, ELM",,,,,,,,,,,
12,12,F,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 9-17, ELM",,,,,,,,,,,
13,13,L,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 9-17, ELM",,,,,,,,,,,
14,14,S,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 9-17, ELM",,,,,,,,,,,
15,15,Y,,,,,,,,,,,C,"GTPase-binding domain (GBD) ligand, 9-17, ELM",,,,,,,,,,,
16,16,K,,,,Ubq,,,,,,,C,"USP7 binding motif, 16-20, ELM|GTPase-binding domain (GBD) ligand, 9-17, ELM",,,,,,,,,,,
17,17,L,,,,,,,,,,,C,"USP7 binding motif, 16-20, ELM|GTPase-binding domain (GBD) ligand, 9-17, ELM",,,,,,,,,,,
18,18,S,F,,,,,,,,,,C,"USP7 binding motif, 16-20, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,20:30309968-30309969, hg38,20:31722165-31722166","hg19,20:g.30309968_30309969delinsAA, hg38,20:g.31722165_31722166delinsAA",,skin,malignant_melanoma,,
19,19,Q,,,,,,,,,,,C,"USP7 binding motif, 16-20, ELM",,,,,,,,,,,
20,20,K,,,,,,,,,,,C,"USP7 binding motif, 16-20, ELM",,,,,,,,,,,
21,21,G,E,,,,,,,,,,C,,,cBioPortal,chol_icgc_2017,Cholangiocarcinoma,"hg19,20:30309960-30309960","hg19,20:g.30309960C>T",0.345,,,,
22,22,Y,,,,,,,,,,,C,,,,,,,,,,,,
23,23,S,I,,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,20:30309954-30309954","hg19,20:g.30309954C>A",0.050,,,,
24,24,W,C,,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM",,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,20:30309950-30309950, hg38,20:31722147-31722147","hg19,20:g.30309950C>G, hg38,20:g.31722147C>G",0.197,breast,carcinoma,,
25,25,S,,,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM|Atg8 protein family ligands, 25-32, ELM",,,,,,,,,,,
26,26,Q,K,,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM|Atg8 protein family ligands, 25-32, ELM",,"cBioPortal,COSMIC",brca_sanger,Invasive Breast Carcinoma,"hg19,20:30309946-30309946, hg38,20:31722143-31722143","hg19,20:g.30309946G>T, hg38,20:g.31722143G>T",0.092,breast,carcinoma,,
27,27,F,L,,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM|Atg8 protein family ligands, 25-32, ELM",,cBioPortal,"luad_msk_npjpo_2021, luad_mskcc_2020, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,20:30309941-30309941","hg19,20:g.30309941A>T",0.052,,,,
28,28,S,,P,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM|Atg8 protein family ligands, 25-32, ELM",,,,,,,,,,,
29,29,D,,,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM|Atg8 protein family ligands, 25-32, ELM",,,,,,,,,,,
30,30,V,,,,,,,,,,,C,"Atg8 protein family ligands, 23-30, ELM|Atg8 protein family ligands, 25-32, ELM",,,,,,,,,,,
31,31,E,V,,,,,,,,,,C,"Atg8 protein family ligands, 25-32, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309930-30309930","hg19,20:g.30309930T>A",0.067,,,,
32,32,E,D,,,,,,,,,,C,"Atg8 protein family ligands, 25-32, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309926-30309926, hg38,20:31722123-31722123","hg19,20:g.30309926C>A, hg38,20:g.31722123C>A",0.066,large_intestine,"carcinoma, adenocarcinoma",,
33,32,E,Q,,,,,,,,,,C,"Atg8 protein family ligands, 25-32, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309928-30309928","hg19,20:g.30309928C>G",0.061,,,,
34,33,N,Y,,,,,,,,,,C,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,20:30309925-30309925","hg19,20:g.30309925T>A",0.076,,,,
35,34,R,K,,,,,,,,,,C,,,cBioPortal,dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,20:30309921-30309921","hg19,20:g.30309921C>T",0.042,,,0.0000050025513012,
36,34,R,M,,,,,,,,,,C,,,COSMIC,,,"hg38,20:31722118-31722118","hg38,20:g.31722118C>A",0.179,stomach,"carcinoma, adenocarcinoma",,
37,35,T,,,,,,,,,,,C,,,,,,,,,,,,
38,36,E,Q,,,,,,,,,,C,,,COSMIC,,,"hg38,20:31722113-31722113","hg38,20:g.31722113C>G",0.082,lung,"carcinoma, non_small_cell_carcinoma",,
39,37,A,T,,,,,,,,,,C,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,20:30309913-30309913","hg19,20:g.30309913C>T",0.068,,,,
40,38,P,,,,,,,,,,,C,,,,,,,,,,,,
41,39,E,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,COSMIC,,,"hg38,20:31722104-31722104","hg38,20:g.31722104C>T",0.087,breast,"carcinoma, ductal_carcinoma",,
42,39,E,V,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309906-30309906, hg38,20:31722103-31722103","hg19,20:g.30309906T>A, hg38,20:g.31722103T>A",0.047,,malignant_melanoma,,
43,40,G,,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,,,,,,,,,,
44,41,T,,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,,,,,,,,,,
45,42,E,D,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,20:30309896-30309896","hg19,20:g.30309896T>A",0.028,,,,
46,42,E,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,20:30309898-30309898","hg19,20:g.30309898C>T",0.056,,,,
47,42,E,Q,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,cBioPortal,"luad_msk_npjpo_2021, luad_mskcc_2020, lung_msk_pdx, msk_met_2021","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,20:30309898-30309898","hg19,20:g.30309898C>G",0.067,,,,
48,43,S,L,,,,,,,,,,C,"FHA phosphopeptide ligands, 39-45, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad, msk_met_2021",Mixed Cancer Types,"hg19,20:30309894-30309894","hg19,20:g.30309894G>A",0.055,,,0.0000570851446889,0.0001592762487258
49,44,E,D,,,,,,,,,,C,"WW domain ligands, 44-49, ELM|FHA phosphopeptide ligands, 39-45, ELM",,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,20:30309890-30309890, hg38,20:31722087-31722087","hg19,20:g.30309890C>A, hg38,20:g.31722087C>A",0.030,breast,carcinoma,,
50,45,M,,,,,,,,,,,C,"Cks1 ligand, 45-50, ELM|WW domain ligands, 44-49, ELM|FHA phosphopeptide ligands, 39-45, ELM",,,,,,,,,,,
51,46,E,Q,,,,,,,,,,C,"Cks1 ligand, 45-50, ELM|WW domain ligands, 44-49, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309886-30309886","hg19,20:g.30309886C>G",0.088,,,,
52,47,T,I,P,,,,,,,,,C,"Cks1 ligand, 45-50, ELM|WW domain ligands, 44-49, ELM",,"cBioPortal,COSMIC",ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,20:30309882-30309882, hg38,20:31722079-31722079","hg19,20:g.30309882G>A, hg38,20:g.31722079G>A",0.050,stomach,carcinoma,,
53,48,P,L,,,,,,,,,,C,"Cks1 ligand, 45-50, ELM|WW domain ligands, 44-49, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309879-30309879","hg19,20:g.30309879G>A",0.094,,,,
54,49,S,,P,,,,,,,,,C,"Cks1 ligand, 45-50, ELM|WW domain ligands, 44-49, ELM",,,,,,,,,,,
55,50,A,T,,,,,,,,,,C,"Cks1 ligand, 45-50, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,20:30309874-30309874","hg19,20:g.30309874C>T",0.049,,,,
56,50,A,V,,,,,,,,,,C,"Cks1 ligand, 45-50, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,20:30309873-30309873, hg38,20:31722070-31722070","hg19,20:g.30309873G>A, hg38,20:g.31722070G>A",0.091,endometrium,"carcinoma, endometrioid_carcinoma",,
57,51,I,,,,,,,,,,,C,,,,,,,,,,,,
58,52,N,S,,,,,,,,,,C,,,cBioPortal,cfdna_msk_2019,Mixed Cancer Types,"hg19,20:30309867-30309867","hg19,20:g.30309867T>C",0.100,,,,
59,53,G,D,,,,,,,,,,C,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,20:30309864-30309864","hg19,20:g.30309864C>T",0.235,,,0.0000124744274238,
60,54,N,,,,,,,,,,,C,,,,,,,,,,,,
61,55,P,S,,,,,,,,,,C,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309859-30309859","hg19,20:g.30309859G>A",0.052,,,0.0000041266723340,
62,56,S,,,,,,,,,,,C,,,,,,,,,,,,
63,57,W,,,,,,,,,,,C,,,,,,,,,,,,
64,58,H,,,,,,,,,,,C,,,,,,,,,,,,
65,59,L,,,,,,,,,,,C,"WW domain ligands, 59-64, ELM",,,,,,,,,,,
66,60,A,V,,,,,,,,,,C,"WW domain ligands, 59-64, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,20:30309843-30309843, hg38,20:31722040-31722040","hg19,20:g.30309843G>A, hg38,20:g.31722040G>A",0.044,"large_intestine, colon, right","carcinoma, adenocarcinoma",0.0000040599574516,
67,61,D,E,,,,,,,,,,C,"WW domain ligands, 59-64, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309839-30309839","hg19,20:g.30309839G>C",0.026,,,0.0000040350891351,
68,62,S,,P,,,,,,,,,C,"WW domain ligands, 59-64, ELM",,,,,,,,,,,
69,63,P,,,,,,,,,,,C,"WW domain ligands, 59-64, ELM",,,,,,,,,,,
70,64,A,T,,,,,,,,,,C,"WW domain ligands, 59-64, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309832-30309832, hg38,20:31722029-31722029","hg19,20:g.30309832C>T, hg38,20:g.31722029C>T",0.019,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000080304514720,
71,64,A,V,,,,,,,,,,C,"WW domain ligands, 59-64, ELM",,cBioPortal,"acc_tcga, acc_tcga_pan_can_atlas_2018",Adrenocortical Carcinoma,"hg19,20:30309831-30309831","hg19,20:g.30309831G>A",0.114,,,,
72,65,V,,,,,,,,,,,C,,,,,,,,,,,,
73,66,N,,,,,,,,,,,C,,,,,,,,,,,,
74,67,G,V,,,,,,,,,,C,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309822-30309822","hg19,20:g.30309822C>A",0.062,,,0.0000039916654026,
75,68,A,D,,,,,,,,,,C,,,cBioPortal,sarcoma_mskcc_2022,Soft Tissue,"hg19,20:30309819-30309819","hg19,20:g.30309819G>T",0.239,,,,
76,69,T,I,,,,,,,,,,C,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309816-30309816","hg19,20:g.30309816G>A",0.089,,,0.0000039846352465,
77,70,G,D,,,,,,,,,,C,,,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,20:30309813-30309813, hg38,20:31722010-31722010","hg19,20:g.30309813C>T, hg38,20:g.31722010C>T",0.083,,malignant_melanoma,0.0000039863825173,
78,71,H,R,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,20:30309810-30309810","hg19,20:g.30309810T>C",0.030,,,,
79,72,S,,,,,,,,,,,C,,,,,,,,,,,,
80,73,S,,,,,,,,,,,C,"Caspase cleavage motif, 73-77, ELM",,,,,,,,,,,
81,74,S,T,,,,,,,,,,C,"Caspase cleavage motif, 73-77, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309801-30309801","hg19,20:g.30309801C>G",0.084,,,,
82,75,L,,,,,,,,,,,C,"Caspase cleavage motif, 73-77, ELM",,,,,,,,,,,
83,76,D,H,,,,,,,,,,C,"Caspase cleavage motif, 73-77, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,20:30309796-30309796, hg38,20:31721993-31721993","hg19,20:g.30309796C>G, hg38,20:g.31721993C>G",0.085,"lung, right_lower_lobe","carcinoma, adenocarcinoma",,
84,77,A,I,,,,,,,,,,C,"Caspase cleavage motif, 73-77, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,20:30309792-30309793","hg19,20:g.30309792_30309793delinsAT",,,,,
85,78,R,W,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309790-30309790","hg19,20:g.30309790G>A",0.136,,,0.0000039799094173,
86,79,E,,,,,,,,,,,C,,,,,,,,,,,,
87,80,V,,,,,,,,,,,C,,,,,,,,,,,,
88,81,I,,,,,,,,,,,C,,,,,,,,,,,,
89,82,P,F,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309777-30309778","hg19,20:g.30309777_30309778delinsAA",,,,,
90,82,P,S,,,,,,,,,,C,,,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,20:30309778-30309778","hg19,20:g.30309778G>A",0.156,,,,
91,83,M,T,,,,,,,,,,C,,,"cBioPortal,COSMIC","luad_msk_npjpo_2021, luad_mskcc_2020, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,20:30309774-30309774, hg38,20:31721971-31721971","hg19,20:g.30309774A>G, hg38,20:g.31721971A>G",0.102,lung,"carcinoma, adenocarcinoma",,
92,84,A,E,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,20:30309771-30309771","hg19,20:g.30309771G>T",0.145,,,,
93,84,A,V,,,,,,,,,,C,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309771-30309771","hg19,20:g.30309771G>A",0.083,,,0.0000039783260795,
94,85,A,S,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309769-30309769","hg19,20:g.30309769C>A",0.023,,,,
95,86,V,,,,,,,,,,,C,,,,,,,,,,,,
96,87,K,,,,Ubq,,,,,,,C,"PCSK cleavage site, 87-91, ELM",,,,,,,,,,,
97,88,Q,E,,,,,,,,,,C,"PCSK cleavage site, 87-91, ELM",,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,20:30309760-30309760, hg38,20:31721957-31721957","hg19,20:g.30309760G>C, hg38,20:g.31721957G>C",0.119,ovary,"carcinoma, serous_carcinoma",,
98,88,Q,L,,,,,,,,,,C,"PCSK cleavage site, 87-91, ELM",,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,20:30309759-30309759","hg19,20:g.30309759T>A",0.116,,,,
99,89,A,T,,,,,,,,,,C,"PCSK cleavage site, 87-91, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309757-30309757","hg19,20:g.30309757C>T",0.148,,,,
100,89,A,V,,,,,,,,,,C,"PCSK cleavage site, 87-91, ELM",,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,20:30309756-30309756, hg38,20:31721953-31721953","hg19,20:g.30309756G>A, hg38,20:g.31721953G>A",0.251,soft_tissue,sarcoma,0.0000079564622386,
101,90,L,,,,,,,,,,,C,"PCSK cleavage site, 87-91, ELM",,,,,,,,,,,
102,91,R,K,,,,,,,,,,S,"PCSK cleavage site, 87-91, ELM",,COSMIC,,,"hg38,20:31721947-31721947","hg38,20:g.31721947C>T",0.182,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
103,91,R,T,,,,,,,,,,S,"PCSK cleavage site, 87-91, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309750-30309750","hg19,20:g.30309750C>G",0.352,,,,
104,92,E,K,,,,,,,,,,S,,,"cBioPortal,COSMIC",uccc_nih_2017,Uterine Clear Cell Carcinoma,"hg19,20:30309748-30309748, hg38,20:31721945-31721945","hg19,20:g.30309748C>T, hg38,20:g.31721945C>T",0.123,endometrium,"carcinoma, mixed_endometrioid_and_clear_cell_carcinoma",,
105,93,A,G,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309744-30309744","hg19,20:g.30309744G>C",0.344,,,,
106,94,G,V,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,20:30309741-30309741","hg19,20:g.30309741C>A",0.306,,,,
107,95,D,N,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309739-30309739","hg19,20:g.30309739C>T",0.140,,,0.0000238699564771,
108,96,E,K,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309736-30309736","hg19,20:g.30309736C>T",0.561,,,,
109,97,F,,,,,,,,,,,S,,,,,,,,,,,,
110,98,E,K,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015","Bladder Urothelial Carcinoma, Invasive Breast Carcinoma","hg19,20:30309730-30309730, hg38,20:31721927-31721927","hg19,20:g.30309730C>T, hg38,20:g.31721927C>T",0.414,"breast, urinary_tract, bladder",carcinoma,,
111,98,E,Q,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309730-30309730","hg19,20:g.30309730C>G",0.323,,,,
112,99,L,,,,,,,,,,,C,,,,,,,,,,,,
113,100,R,W,,,,,,,,,,C,"PCSK cleavage site, 100-104, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309724-30309724, hg38,20:31721921-31721921","hg19,20:g.30309724G>A, hg38,20:g.31721921G>A",0.391,"large_intestine, caecum","carcinoma, adenocarcinoma",,
114,101,Y,C,,,,,,,,,,C,"PCSK cleavage site, 100-104, ELM|di Arginine retention/retrieving signal, 101-103, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309720-30309720","hg19,20:g.30309720T>C",0.626,,,,
115,102,R,,,,,,,,,,,C,"NRD cleavage site, 102-104, ELM|PCSK cleavage site, 100-104, ELM|PCSK cleavage site, 102-106, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|di Arginine retention/retrieving signal, 101-103, ELM",,,,,,,,,,,
116,103,R,Q,,,,,,,,,,C,"NRD cleavage site, 102-104, ELM|PCSK cleavage site, 100-104, ELM|PCSK cleavage site, 102-106, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|di Arginine retention/retrieving signal, 101-103, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309714-30309714","hg19,20:g.30309714C>T",0.107,,,,
117,103,R,W,,,,,,,,,,C,"NRD cleavage site, 102-104, ELM|PCSK cleavage site, 100-104, ELM|PCSK cleavage site, 102-106, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|di Arginine retention/retrieving signal, 101-103, ELM",,COSMIC,,,"hg38,20:31721912-31721912","hg38,20:g.31721912G>A",0.270,stomach,carcinoma,,
118,104,A,G,,,,,,,,,,C,"NRD cleavage site, 102-104, ELM|PCSK cleavage site, 100-104, ELM|PCSK cleavage site, 102-106, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM",,COSMIC,,,"hg38,20:31721908-31721908","hg38,20:g.31721908G>C",0.222,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,
119,105,F,,,,,,,,,,,C,"PCSK cleavage site, 102-106, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM",,,,,,,,,,,
120,106,S,G,,,,,,,,,,C,"PCSK cleavage site, 102-106, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM",,cBioPortal,lihc_amc_prv,Hepatocellular Carcinoma,"hg19,20:30309706-30309706","hg19,20:g.30309706T>C",0.159,,,,
121,106,S,R,,,,,,,,,,C,"PCSK cleavage site, 102-106, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM",,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,20:30309704-30309704, hg38,20:31721901-31721901","hg19,20:g.30309704A>T, hg38,20:g.31721901A>T",0.236,ovary,"carcinoma, serous_carcinoma",,
122,107,D,N,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|FHA phosphopeptide ligands, 107-113, ELM",,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,20:30309703-30309703, hg38,20:31721900-31721900","hg19,20:g.30309703C>T, hg38,20:g.31721900C>T",0.179,oesophagus,"carcinoma, adenocarcinoma",,
123,108,L,,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|FHA phosphopeptide ligands, 107-113, ELM",,,,,,,,,,,
124,109,T,A,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|FHA phosphopeptide ligands, 107-113, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,20:30309697-30309697, hg38,20:31721894-31721894","hg19,20:g.30309697T>C, hg38,20:g.31721894T>C",0.080,"large_intestine, caecum","carcinoma, adenocarcinoma",,
125,110,S,,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|FHA phosphopeptide ligands, 107-113, ELM",,,,,,,,,,,
126,111,Q,E,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|FHA phosphopeptide ligands, 107-113, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309691-30309691","hg19,20:g.30309691G>C",0.397,,,,
127,112,L,V,,,,,,,,,,C,"WW domain ligands, 112-117, ELM|14-3-3 binding phosphopeptide motif, 102-112, ELM|14-3-3 binding phosphopeptide motif, 103-112, ELM|FHA phosphopeptide ligands, 107-113, ELM",,COSMIC,,,"hg38,20:31721885-31721885","hg38,20:g.31721885G>C",0.500,lung,"carcinoma, adenocarcinoma",,
128,113,H,R,,,,,,,,,,C,"WW domain ligands, 112-117, ELM|FHA phosphopeptide ligands, 107-113, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,20:30309684-30309684","hg19,20:g.30309684T>C",0.431,,,,
129,113,H,Y,,,,,,,,,,C,"WW domain ligands, 112-117, ELM|FHA phosphopeptide ligands, 107-113, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,20:30309685-30309685, hg38,20:31721882-31721882","hg19,20:g.30309685G>A, hg38,20:g.31721882G>A",0.529,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
130,114,I,,,,,,,,,,,C,"WW domain ligands, 112-117, ELM",,,,,,,,,,,
131,115,T,,P,,,,,,,,,C,"WW domain ligands, 112-117, ELM",,,,,,,,,,,
132,116,P,,,,,,,,,,,C,"WW domain ligands, 112-117, ELM",,,,,,,,,,,
133,117,G,E,,,,,,,,,,C,"WW domain ligands, 112-117, ELM",,"cBioPortal,COSMIC","gct_msk_2016, msk_impact_2017","Mixed Cancer Types, Testis","hg19,20:30309672-30309672, hg38,20:31721869-31721869","hg19,20:g.30309672C>T, hg38,20:g.31721869C>T",0.062,"genital_tract, extragonadal, mediastinum","germ_cell_tumour, choriocarcinoma",0.0000039764909853,
134,118,T,,,,,,,,,,,C,"Atg8 protein family ligands, 118-127, ELM",,,,,,,,,,,
135,119,A,V,,,,,,,,,,C,"USP7 binding motif, 119-123, ELM|Atg8 protein family ligands, 118-127, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309666-30309666, hg38,20:31721863-31721863","hg19,20:g.30309666G>A, hg38,20:g.31721863G>A",0.280,"large_intestine, caecum","carcinoma, adenocarcinoma",,
136,120,Y,,,,,,,,,,,S,"USP7 binding motif, 119-123, ELM|Atg8 protein family ligands, 118-127, ELM|WAVE regulatory complex (WRC) binding site motif, 120-125, ELM|Y-based sorting signal, 120-123, ELM",,,,,,,,,,,
137,121,Q,H,,,,,,,,,,S,"USP7 binding motif, 119-123, ELM|Atg8 protein family ligands, 118-127, ELM|WAVE regulatory complex (WRC) binding site motif, 120-125, ELM|Y-based sorting signal, 120-123, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,20:30309659-30309659, hg38,20:31721856-31721856","hg19,20:g.30309659C>G, hg38,20:g.31721856C>G",0.214,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,
138,121,Q,P,,,,,,,,,,S,"USP7 binding motif, 119-123, ELM|Atg8 protein family ligands, 118-127, ELM|WAVE regulatory complex (WRC) binding site motif, 120-125, ELM|Y-based sorting signal, 120-123, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,20:30309660-30309660, hg38,20:31721857-31721857","hg19,20:g.30309660T>G, hg38,20:g.31721857T>G",0.331,"large_intestine, colon","carcinoma, adenocarcinoma",,
139,122,S,N,,,,,,,,,,S,"USP7 binding motif, 119-123, ELM|Atg8 protein family ligands, 118-127, ELM|Atg8 protein family ligands, 122-131, ELM|WAVE regulatory complex (WRC) binding site motif, 120-125, ELM|Y-based sorting signal, 120-123, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309657-30309657","hg19,20:g.30309657C>T",0.166,,,,
140,123,F,,,,,,,,,,,S,"USP7 binding motif, 119-123, ELM|Atg8 protein family ligands, 118-127, ELM|Atg8 protein family ligands, 122-131, ELM|WAVE regulatory complex (WRC) binding site motif, 120-125, ELM|Y-based sorting signal, 120-123, ELM",,,,,,,,,,,
141,124,E,Q,,,,,,,,,,S,"Atg8 protein family ligands, 118-127, ELM|Atg8 protein family ligands, 122-131, ELM|WAVE regulatory complex (WRC) binding site motif, 120-125, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309652-30309652","hg19,20:g.30309652C>G",0.175,,,0.0000039763644895,
142,125,Q,L,,,,,,,,,,S,"Atg8 protein family ligands, 118-127, ELM|Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM|WAVE regulatory complex (WRC) binding site motif, 120-125, ELM",,COSMIC,,,"hg38,20:31721845-31721845","hg38,20:g.31721845T>A",0.160,"skin, mucosal, nasopharynx",malignant_melanoma,,
143,126,V,,,,,,,,,,,S,"Atg8 protein family ligands, 118-127, ELM|Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM",,,,,,,,,,,
144,127,V,,,,,,,,,,,S,"Atg8 protein family ligands, 118-127, ELM|Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM",,,,,,,,,,,
145,128,N,,,,,,,,,,,S,"Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM",,,,,,,,,,,
146,129,E,,,,,,,,,,,S,"Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM",,,,,,,,,,,
147,130,L,F,,,,,,,,,,S,"Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309634-30309634","hg19,20:g.30309634G>A",0.379,,,,
148,130,L,V,,,,,,,,,,S,"Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM",,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,20:30309634-30309634","hg19,20:g.30309634G>C",0.162,,,,
149,131,F,,,,,,,,,,,S,"Atg8 protein family ligands, 122-131, ELM|PTB ligand, 125-132, ELM",,,,,,,,,,,
150,132,R,Q,,,,,,,,,,S,"PTB ligand, 125-132, ELM",,"cBioPortal,COSMIC","blca_mskcc_solit_2014, ov_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, High-Grade Serous Ovarian Cancer","hg19,20:30309627-30309627, hg38,20:31721824-31721824","hg19,20:g.30309627C>T, hg38,20:g.31721824C>T",0.104,ovary,"carcinoma, serous_carcinoma",0.0000318111689014,
151,132,R,W,,,,,,,,,,S,"PTB ligand, 125-132, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, coadread_dfci_2016, pan_origimed_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309628-30309628, hg38,20:31721825-31721825","hg19,20:g.30309628G>A, hg38,20:g.31721825G>A",0.247,large_intestine,"carcinoma, adenocarcinoma",,
152,133,D,,,,,,,,,,,S,,,,,,,,,,,,
153,134,G,E,,,,,,,,,,S,,,COSMIC,,,"hg38,20:31721818-31721818","hg38,20:g.31721818C>T",0.418,prostate,carcinoma,0.0000039763012446,0.0000318694626809
154,135,V,I,,,,,,,,,,S,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,20:30309619-30309619, hg38,20:31721816-31721816","hg19,20:g.30309619C>T, hg38,20:g.31721816C>T",0.102,large_intestine,"carcinoma, adenocarcinoma",,
155,136,N,K,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad, lymphoma_cellline_msk_2020","Lymphoid, Mixed Cancer Types","hg19,20:30309614-30309614","hg19,20:g.30309614G>C",0.478,,,0.0000039762380017,
156,137,W,,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM",,,,,,,,,,,
157,138,G,S,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,20:30309610-30309610, hg38,20:31721807-31721807","hg19,20:g.30309610C>T, hg38,20:g.31721807C>T",0.716,,malignant_melanoma,,
158,139,R,,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM",,,,,,,,,,,
159,140,I,,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM",,,,,,,,,,,
160,141,V,,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM",,,,,,,,,,,
161,142,A,,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM",,,,,,,,,,,
162,143,F,L,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM|WAVE regulatory complex (WRC) binding site motif, 143-148, ELM",,"cBioPortal,COSMIC","esca_tcga, esca_tcga_pan_can_atlas_2018, skcm_broad_brafresist_2012, stes_tcga_pub, tgct_tcga","Cutaneous Melanoma, Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Non-Seminomatous Germ Cell Tumor","hg19,20:30309595-30309595, hg38,20:31721792-31721792","hg19,20:g.30309595A>G, hg38,20:g.31721792A>G",0.213,,malignant_melanoma,,
163,144,F,L,,,,,,,,,,S,"PP1-docking motif RVXF, 137-144, ELM|WAVE regulatory complex (WRC) binding site motif, 143-148, ELM",,"cBioPortal,COSMIC","msk_impact_2017, sarcoma_mskcc_2022","Mixed Cancer Types, Soft Tissue","hg19,20:30309590-30309590, hg38,20:31721787-31721787","hg19,20:g.30309590G>C, hg38,20:g.31721787G>C",0.286,bone,Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour,,
164,145,S,,P,,,,,,,,,S,"WAVE regulatory complex (WRC) binding site motif, 143-148, ELM",,,,,,,,,,,
165,146,F,,,,,,,,,,,S,"WAVE regulatory complex (WRC) binding site motif, 143-148, ELM",,,,,,,,,,,
166,147,G,C,,,,,,,,,,S,"WAVE regulatory complex (WRC) binding site motif, 143-148, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,20:30309583-30309583","hg19,20:g.30309583C>A",0.651,,,,
167,147,G,S,,,,,,,,,,S,"WAVE regulatory complex (WRC) binding site motif, 143-148, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309583-30309583","hg19,20:g.30309583C>T",0.546,,,,
168,148,G,V,,,,,,,,,,S,"WAVE regulatory complex (WRC) binding site motif, 143-148, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,20:30309579-30309579, hg38,20:31721776-31721776","hg19,20:g.30309579C>A, hg38,20:g.31721776C>A",0.626,kidney,"carcinoma, renal_cell_carcinoma",,
169,149,A,E,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,20:30309576-30309576, hg38,20:31721773-31721773","hg19,20:g.30309576G>T, hg38,20:g.31721773G>T",0.525,"urinary_tract, bladder",carcinoma,,
170,149,A,S,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309577-30309577","hg19,20:g.30309577C>A",0.286,,,,
171,150,L,,,,,,,,,,,S,,,,,,,,,,,,
172,151,C,Y,,,,,,,,,,S,,,COSMIC,,,"hg38,20:31721767-31721767","hg38,20:g.31721767C>T",0.567,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
173,152,V,M,,,,,,,,,,S,,,"cBioPortal,COSMIC","cfdna_msk_2019, coadread_tcga_pan_can_atlas_2018, crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309568-30309568, hg38,20:31721765-31721765","hg19,20:g.30309568C>T, hg38,20:g.31721765C>T",0.330,"large_intestine, colon, large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000079524127620,0.0000318674314850
174,153,E,K,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309565-30309565","hg19,20:g.30309565C>T",0.469,,,,
175,154,S,I,,,,,,,,,,S,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,20:30309561-30309561, hg38,20:31721758-31721758","hg19,20:g.30309561C>A, hg38,20:g.31721758C>A",0.315,lung,"carcinoma, squamous_cell_carcinoma",,
176,154,S,N,,,,,,,,,,S,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,20:30309561-30309561, hg38,20:31721758-31721758","hg19,20:g.30309561C>T, hg38,20:g.31721758C>T",0.243,endometrium,"carcinoma, endometrioid_carcinoma",,
177,155,V,I,,,,,,,,,,S,,,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309559-30309559, hg38,20:31721756-31721756","hg19,20:g.30309559C>T, hg38,20:g.31721756C>T",0.220,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",0.0000039763644895,
178,156,D,,,,,,,,,,,C,,,,,,,,,,,,
179,157,K,,,,,,,,,,,C,,,,,,,,,,,,
180,158,E,,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 158-163, ELM",,,,,,,,,,,
181,159,M,T,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 158-163, ELM",,COSMIC,,,"hg38,20:31721743-31721743","hg38,20:g.31721743A>G",0.490,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, adult_T_cell_lymphoma-leukaemia",,
182,160,Q,H,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 158-163, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309542-30309542, hg38,20:31721739-31721739","hg19,20:g.30309542C>A, hg38,20:g.31721739C>A",0.059,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
183,161,V,A,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 158-163, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,20:30309540-30309540","hg19,20:g.30309540A>G",0.050,,,,
184,161,V,L,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 158-163, ELM",,cBioPortal,mpnst_mskcc,Malignant Peripheral Nerve Sheath Tumor,"hg19,20:30309541-30309541","hg19,20:g.30309541C>G",0.062,,,,
185,162,L,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 158-163, ELM",,,,,,,,,,,
186,163,V,L,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 158-163, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309535-30309535","hg19,20:g.30309535C>A",0.384,,,,
187,164,S,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM",,,,,,,,,,,
188,165,R,W,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM",,"cBioPortal,COSMIC","esca_broad, pan_origimed_2020","Esophageal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309529-30309529, hg38,20:31721726-31721726","hg19,20:g.30309529G>A, hg38,20:g.31721726G>A",0.291,oesophagus,"carcinoma, adenocarcinoma",,
189,166,I,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM",,,,,,,,,,,
190,167,A,T,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM",,"cBioPortal,COSMIC",stad_tcga_pan_can_atlas_2018,Stomach Adenocarcinoma,"hg19,20:30309523-30309523, hg38,20:31721720-31721720","hg19,20:g.30309523C>T, hg38,20:g.31721720C>T",0.086,stomach,"carcinoma, adenocarcinoma",0.0000159169770477,0.0000956388676358
191,168,A,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM",,,,,,,,,,,
192,169,W,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM|Pex14 ligand motif, 169-173, ELM",,,,,,,,,,,
193,170,M,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 162-170, ELM|Pex14 ligand motif, 169-173, ELM",,,,,,,,,,,
194,171,A,T,,,,,,,,,,S,"Pex14 ligand motif, 169-173, ELM",,cBioPortal,"msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,20:30309511-30309511","hg19,20:g.30309511C>T",0.115,,,,
195,171,A,V,,,,,,,,,,S,"Pex14 ligand motif, 169-173, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, tmb_mskcc_2018","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309510-30309510, hg38,20:31721707-31721707","hg19,20:g.30309510G>A, hg38,20:g.31721707G>A",0.222,"large_intestine, rectum","carcinoma, adenocarcinoma",,
196,172,T,,,,,,,,,,,S,"Pex14 ligand motif, 169-173, ELM",,,,,,,,,,,
197,173,Y,,,,,,,,,,,S,"Pex14 ligand motif, 169-173, ELM|Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM",,,,,,,,,,,
198,174,L,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM",,,,,,,,,,,
199,175,N,I,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,20:30309498-30309498","hg19,20:g.30309498T>A",0.177,,,,
200,175,N,T,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,20:30309498-30309498, hg38,20:31721695-31721695","hg19,20:g.30309498T>G, hg38,20:g.31721695T>G",0.065,endometrium,"carcinoma, endometrioid_carcinoma",,
201,176,D,N,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM|Phosphotyrosine ligands bound by SH2 domains, 173-176, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309496-30309496","hg19,20:g.30309496C>T",0.146,,,,
202,177,H,,,,,,,,,,,C,,,,,,,,,,,,
203,178,L,,,,,,,,,,,S,,,,,,,,,,,,
204,179,E,K,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30309487-30309487","hg19,20:g.30309487C>T",0.067,,,,
205,180,P,L,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,cBioPortal,"luad_msk_npjpo_2021, luad_mskcc_2020, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,20:30309483-30309483","hg19,20:g.30309483G>A",0.257,,,0.0000200158525552,
206,181,W,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,,,,,,,,,,
207,182,I,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,,,,,,,,,,
208,183,Q,H,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,20:30309473-30309473","hg19,20:g.30309473C>A",0.149,,,,
209,184,E,,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,,,,,,,,,,
210,185,N,,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,,,,,,,,,,
211,186,G,D,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,20:30309465-30309465, hg38,20:31721662-31721662","hg19,20:g.30309465C>T, hg38,20:g.31721662C>T",0.532,skin,malignant_melanoma,,
212,186,G,S,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,20:30309466-30309466, hg38,20:31721663-31721663","hg19,20:g.30309466C>T, hg38,20:g.31721663C>T",0.563,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000040736184323,
213,187,G,S,,,,,,,,,,C,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,20:30309463-30309463, hg38,20:31721660-31721660","hg19,20:g.30309463C>T, hg38,20:g.31721660C>T",0.712,ovary,"carcinoma, serous_carcinoma",0.0000081998802817,
214,188,W,C,,,,,,,,,,S,"FHA phosphopeptide ligands, 188-194, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 179-188, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30309458-30309458","hg19,20:g.30309458C>A",0.739,,,,
215,189,D,E,,,,,,,,,,S,"FHA phosphopeptide ligands, 188-194, ELM|Atg8 protein family ligands, 189-199, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,20:30253887-30253887","hg19,20:g.30253887A>T",0.126,,,,
216,190,T,S,,,,,,,,,,S,"FHA phosphopeptide ligands, 188-194, ELM|Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,20:30253885-30253885, hg38,20:31666082-31666082","hg19,20:g.30253885G>C, hg38,20:g.31666082G>C",0.097,ovary,"carcinoma, serous_carcinoma",,
217,191,F,,,,,,,,,,,C,"FHA phosphopeptide ligands, 188-194, ELM|Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,,,,,,,,,,
218,192,V,M,,,,,,,,,,C,"FHA phosphopeptide ligands, 188-194, ELM|Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,cBioPortal,prad_pik3r1_msk_2021,Prostate Adenocarcinoma,"hg19,20:30253880-30253880","hg19,20:g.30253880C>T",0.094,,,,
219,193,E,G,,,,,,,,,,C,"FHA phosphopeptide ligands, 188-194, ELM|Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,"cBioPortal,COSMIC","msk_impact_2017, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,20:30253876-30253876, hg38,20:31666073-31666073","hg19,20:g.30253876T>C, hg38,20:g.31666073T>C",0.122,endometrium,"carcinoma, clear_cell_carcinoma",,
220,194,L,,,,,,,,,,,C,"FHA phosphopeptide ligands, 188-194, ELM|Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,,,,,,,,,,
221,195,Y,,,,,,,,,,,C,"Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,,,,,,,,,,
222,196,G,E,,,,,,,,,,C,"Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30253866-30253867","hg19,20:g.30253866_30253867delinsTT",,,,,
223,197,N,,,,,,,,,,,C,"Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,,,,,,,,,,
224,198,N,D,,,,,,,,,,C,"Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,cBioPortal,gbc_msk_2018,Gallbladder Cancer,"hg19,20:30253862-30253862","hg19,20:g.30253862T>C",0.031,,,,
225,198,N,S,,,,,,,,,,C,"Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,20:30253861-30253861, hg38,20:31666058-31666058","hg19,20:g.30253861T>C, hg38,20:g.31666058T>C",0.069,endometrium,"carcinoma, endometrioid_carcinoma",,
226,199,A,,,,,,,,,,,C,"Atg8 protein family ligands, 189-199, ELM|Atg8 protein family ligands, 190-199, ELM",,,,,,,,,,,
227,200,A,T,,,,,,,,,,C,"USP7 binding motif, 200-204, ELM",,COSMIC,,,"hg38,20:31666053-31666053","hg38,20:g.31666053C>T",0.143,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
228,201,A,T,,,,,,,,,,C,"USP7 binding motif, 200-204, ELM",,cBioPortal,"ucs_tcga, ucs_tcga_pan_can_atlas_2018",Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,"hg19,20:30253853-30253853","hg19,20:g.30253853C>T",0.112,,,,
229,202,E,D,,,,,,,,,,C,"USP7 binding motif, 200-204, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30253848-30253848","hg19,20:g.30253848C>G",0.061,,,,
230,202,E,K,,,,,,,,,,C,"USP7 binding motif, 200-204, ELM",,"cBioPortal,COSMIC","gbm_tcga_pan_can_atlas_2018, msk_met_2021","Glioblastoma Multiforme, Mixed Cancer Types","hg19,20:30253850-30253850, hg38,20:31666047-31666047","hg19,20:g.30253850C>T, hg38,20:g.31666047C>T",0.134,"central_nervous_system, brain, stomach","carcinoma, intestinal_adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000721546996761,
231,203,S,,,,,,,,,,,C,"NRD cleavage site, 203-205, ELM|USP7 binding motif, 200-204, ELM",,,,,,,,,,,
232,204,R,Q,,,,,,,,,,C,"NRD cleavage site, 203-205, ELM|USP7 binding motif, 200-204, ELM",,"cBioPortal,COSMIC","msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,20:30253843-30253843, hg38,20:31666040-31666040","hg19,20:g.30253843C>T, hg38,20:g.31666040C>T",0.074,"large_intestine, rectum","carcinoma, adenocarcinoma",,
233,205,K,,,,,,,,,,,C,"NRD cleavage site, 203-205, ELM",,,,,,,,,,,
234,206,G,S,,,,,,,,,,C,,,COSMIC,,,"hg38,20:31666035-31666035","hg38,20:g.31666035C>T",0.124,"skin, head_neck","malignant_melanoma, superficial_spreading",,
235,207,Q,,,,,,,,,,,C,,,,,,,,,,,,
236,208,E,,,,,,,,,,,C,,,,,,,,,,,,
237,209,R,C,,,,,,,,,,C,,,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016, crc_nigerian_2020, msk_met_2021, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,20:30253829-30253829, hg38,20:31666026-31666026","hg19,20:g.30253829G>A, hg38,20:g.31666026G>A",0.160,large_intestine,"carcinoma, adenocarcinoma",0.0000160088368780,0.0000318552497452
238,209,R,H,,,,,,,,,,C,,,COSMIC,,,"hg38,20:31666025-31666025","hg38,20:g.31666025C>T",0.087,"skin, skin, back",malignant_melanoma,0.0000120061471473,
239,210,F,,,,,,,,,,,C,,,,,,,,,,,,
240,211,N,D,,,,,,,,,,C,,,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,20:30253823-30253823, hg38,20:31666020-31666020","hg19,20:g.30253823T>C, hg38,20:g.31666020T>C",0.097,endometrium,"carcinoma, endometrioid_carcinoma",,
241,212,R,C,,,,,,,,,,C,,,"cBioPortal,COSMIC","glioma_mskcc_2019, lung_pdx_msk_2021, msk_impact_2017","Diffuse Glioma, Lung, Mixed Cancer Types","hg19,20:30253820-30253820, hg38,20:31666017-31666017","hg19,20:g.30253820G>A, hg38,20:g.31666017G>A",0.127,"central_nervous_system, brain, large_intestine","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000040000320003,
242,213,W,,,,,,,,,,,S,,,,,,,,,,,,
243,214,F,,,,,,,,,,,S,,,,,,,,,,,,
244,215,L,,,,,,,,,,,S,,,,,,,,,,,,
245,216,T,M,,,,,,,,,,S,,,"cBioPortal,COSMIC","coadread_dfci_2016, coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, egc_msk_2017, egc_msk_tp53_ccr_2022, egc_mskcc_2020, msk_impact_2017, pan_origimed_2020","Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types","hg19,20:30253807-30253807, hg38,20:31666004-31666004","hg19,20:g.30253807G>A, hg38,20:g.31666004G>A",0.064,"large_intestine, large_intestine, colon, ascending, oesophagus",", carcinoma, adenocarcinoma",0.0000000000000000,
246,217,G,D,,,,,,,,,,S,,,"cBioPortal,COSMIC",pact_jhu_2011,Cystic Tumor of the Pancreas,"hg19,20:30253804-30253804, hg38,20:31666001-31666001","hg19,20:g.30253804C>T, hg38,20:g.31666001C>T",0.259,pancreas,"other, adenoma",,
247,218,M,I,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, cfdna_msk_2019, msk_impact_2017","Breast, Mixed Cancer Types","hg19,20:30253800-30253800, hg38,20:31665997-31665997","hg19,20:g.30253800C>A, hg19,20:g.30253800C>T, hg38,20:g.31665997C>A, hg38,20:g.31665997C>T",0.058,", breast","carcinoma, ductal_carcinoma, carcinoma, of_unknown_primary",,
248,219,T,N,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30253798-30253798","hg19,20:g.30253798G>T",0.114,,,,
249,220,V,,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM",,,,,,,,,,,
250,221,A,V,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM",,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,20:30253792-30253792, hg38,20:31665989-31665989","hg19,20:g.30253792G>A, hg38,20:g.31665989G>A",0.117,endometrium,"carcinoma, endometrioid_carcinoma",,
251,222,G,,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM",,,,,,,,,,,
252,223,V,,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM",,,,,,,,,,,
253,224,V,F,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM",,cBioPortal,cll_broad_2015,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,"hg19,20:30253784-30253784","hg19,20:g.30253784C>A",0.126,,,,
254,225,L,,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,,,,,,,,,,
255,226,L,,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,,,,,,,,,,
256,227,G,A,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad, cellline_nci60",Mixed Cancer Types,"hg19,20:30253774-30253774","hg19,20:g.30253774C>G",0.218,,,,
257,227,G,C,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_pd1_msk_2018, nsclc_tcga_broad_2016, tmb_mskcc_2018","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,20:30253775-30253775, hg19,20:30253775-30253776, hg38,20:31665972-31665972","hg19,20:g.30253775C>A, hg19,20:g.30253775_30253776delinsAG, hg38,20:g.31665972C>A",0.333,lung,"carcinoma, squamous_cell_carcinoma",,
258,228,S,A,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|SUMO interaction site, 222-228, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,20:30253772-30253772, hg38,20:31665969-31665969","hg19,20:g.30253772A>C, hg38,20:g.31665969A>C",0.103,pancreas,"carcinoma, ductal_carcinoma",,
259,229,L,F,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,20:30253769-30253769","hg19,20:g.30253769G>A",0.079,,,,
260,229,L,H,,,,,,,,,,S,"MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,20:30253768-30253768, hg38,20:31665965-31665965","hg19,20:g.30253768A>T, hg38,20:g.31665965A>T",0.310,stomach,"carcinoma, adenocarcinoma",,
261,230,F,,,,,,,,,,,C,"MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,,,,,,,,,,
262,231,S,G,,,,,,,,,,C,"NRD cleavage site, 231-233, ELM|MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,20:30253763-30253763, hg38,20:31665960-31665960","hg19,20:g.30253763T>C, hg38,20:g.31665960T>C",0.066,endometrium,"carcinoma, endometrioid_carcinoma",,
263,231,S,I,,,,,,,,,,C,"NRD cleavage site, 231-233, ELM|MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,20:30253762-30253762","hg19,20:g.30253762C>A",0.166,,,,
264,232,R,Q,,,,,,,,,,C,"NRD cleavage site, 231-233, ELM|MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,"cBioPortal,COSMIC","brca_mbcproject_2022, crc_msk_2017, msk_met_2021","Colorectal Adenocarcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,20:30253759-30253759, hg38,20:31665956-31665956","hg19,20:g.30253759C>T, hg38,20:g.31665956C>T",0.072,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0000039880995111,
265,232,R,W,,,,,,,,,,C,"NRD cleavage site, 231-233, ELM|MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,20:30253760-30253760","hg19,20:g.30253760G>A",0.270,,,0.0000039880677014,
266,233,K,,,,,,,,,,,C,"NRD cleavage site, 231-233, ELM|MAPK docking motifs, 218-233, ELM|Binding motif for UBA3 adenylation domain, 225-233, ELM",,,,,,,,,,,
